An optimized polyamine moiety boosts the potency of human type II topoisomerase poisons as quantified by comparative analysis centered on the clinical candidate F145121. Issue 76 (10th October 2015) - Palermo, Giulia
Abstract Computational–experimental analyses explain F14512's boosted potency as a topoII poison.